About this trial
This study aims to assess the effectiveness of the Serratus Posterior Superior Intercostal Plane Block (SPSIP Block) for postoperative pain control, reducing opioid analgesic consumption, minimizing postoperative respiratory complications, and enhancing patient satisfaction (measured using the QoR-15 index) in patients undergoing robotic thymectomy, compared to patients who do not receive the block.
Eligibility criteria
Qualifiers
Patients affected by thymoma, thymic hyperplasia, or thymic pathologies (cysts, teratomas) who have given informed consent to the study.
Disqualifiers
Patients who refuse to participate in the study by not signing the informed consent;
Patients with myasthenia gravis, severe obesity (BMI > 35), history of OSAS with or without CPAP;
Patients belonging to ASA classes > 3, according to the system developed by the American Society of Anesthesiologists;
Patients unable to understand the functioning of the NPR Scale or the PCA device that will be used for postoperative analgesia;
Trial design
Treatments tested in this trial
- Ultrasound-guided Serratus Posterior Superior Intercostal Plane Block performed with 0.25% bupivacaine
- Ultrasound-guided Serratus Posterior Superior Intercostal Plane Block performed with a placebo solution (0.9% NaCl)